BofA Sees Many Catalysts On Eli Lilly's Horizon

By: via Benzinga
In a report published Tuesday, BofA Merrill Lynch analysts maintained a Neutral rating on Eli Lilly and Co (NASDAQ: LLY), with a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.